Lupin receives tentative U.S. FDA approval for apixaban oral suspension 1.25mg/ml via 505(b)(2)
Company says final approval would allow manufacture of the oral suspension at its Somerset, New Jersey facility.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.